Retrospective studies have suggested that aneurysm morphology is a risk factor for subarachnoid hemorrhage (SAH). OBJECTIVE: To investigate whether various morphological indices of unruptured intracranial aneurysms (UIAs) predict a future rupture. METHODS: A total of 142 patients with UIAs diagnosed between 1956 and 1978 were followed prospectively until SAH, death, or the last contact. Morphological UIA indices from standard angiographic projections were measured at baseline and adjusted in multivariable Cox proportional hazards regression analyses for established risk factors for SAH. RESULTS: During a follow-up of 3064 person-years, 34 patients suffered from an aneurysm rupture. In multivariable analyses, aneurysm volume, volume-to-ostium area ratio, and the bottleneck factor separately as continuous variables predicted aneurysm rupture. All the morphological indices were higher (P < .01) after the rupture than before. In final multivariable analyses, current smoking (adjusted hazard ratio 2.50, 95% CI 1.03-6.10, P = .044), location in the anterior communicating artery (4.28, 1.38-13.28, P = .012), age (inversely; 0.95 per year, 0.91-1.00, P = .043), and UIA diameter ≥7 mm at baseline (2.68, 1.16-6.21, P = .021) were independent risk factors for a future rupture. Aneurysm growth during the followup was associated with smoking (P < .05) and SAH (P < .001), but not with the aneurysm indices. CONCLUSION: Of the morphological indices, UIA volume seems to predict a future rupture. However, as volume correlates with the maximum diameter of the aneurysm, it seems to add little to the predictive value of the maximum diameter. Retrospective studies using indices that are measured after rupture are of little value in risk prediction.
S
ubarachnoid hemorrhage (SAH) is a deadly disease with high case fatality (about 40%). 1, 2 This is one of the reasons why unruptured intracranial aneurysms (UIAs) are often treated when found. [2] [3] [4] Because of the increasing use of magnetic resonance imaging (MRI), MR angiography, and 3-dimensional CT angiography (CTA) for examining symptoms unrelated to UIAs (chronic headache, dizziness, nausea, visual disorders, etc.), asymptomatic UIAs are being detected more and more Supplemental digital content is available for this article at www.neurosurgery-online.com. frequently. [2] [3] [4] As numbers of neuroimaging examinations are likely to increase in the future, numbers of diagnosed UIAs will probably also increase.
According to a recent review, 5 the prevalence of UIAs in adult populations is approximately 3%, and 93% of these are <10 mm in size and 66% are <5 mm. According to the largest and most comprehensive follow-up studies of UIAs, [6] [7] [8] [9] the risk factors for a rupture are reported to be a maximum UIA size of ≥7 mm, location in the anterior communicating, posterior communicating, or vertebrobasilar artery, smoking, age, a history of hypertension, and female sex. In addition to the size of the UIA, retrospective studies have identified several morphological parameters as potential predictors of a rupture: volume of the aneurysm, 10 aspect ratio, [11] [12] [13] [14] [15] the bottleneck factor, 13 heightwidth ratio, 13 and volume-to-ostium area ratio (VOR). 15 The results have been conflicting, however. In all these studies the indices were measured after the rupture of the aneurysm, questioning the reliability and predictive value of the measures. Prospective follow-up studies are therefore needed to estimate the true predictive value of UIA indices. Until very recently, only 2 prospective studies had been done. [16] [17] In these multicenter studies with a treatment selection bias (exclusion of aneurysms with a higher rupture risk) and with a short-term follow-up (mean 2 yr), there were only 0 17 and 3 16 aneurysm ruptures. Therefore, morphology parameters for rupture could not be analyzed. In the first study, 16 bottleneck factor (dome/neck ratio), however, predicted aneurysm growth.
As it is nowadays difficult, or even impossible, to conduct an unselected prospective study of UIA indices as risk factors for a future SAH, we made use of our long-term cohort of patients with UIAs, which were not operated on in our country prior to 1979. This prospective follow-up study investigates the significance of UIA indices in predicting a future SAH.
METHODS

Patient Population
The cohort included 142 patients with 182 UIAs diagnosed between 1956 and 1978 at our institution, which was at that time responsible for neurosurgical services for near the whole population of our country. All the patients gave their written informed consent. Approval for the surveys and follow-up data collection was obtained from the local ethics committee and all aspects of the study were in compliance with national legislation and the Declaration of Helsinki.
Classification of Unruptured Aneurysms
Most patients (n = 131) had multiple aneurysms, but only the ruptured one was treated surgically. Verification of the ruptured aneurysm was based on intraoperative surgical observations and the results of the treatment were confirmed by postoperative angiography. Additional evidence supporting the identification of the rupture site was based on the following findings: the greater size of the ruptured aneurysm in 10 patients, aneurysm size, and the presence of a secondary sac in 69 patients, intracerebral hematoma at the site of the ruptured aneurysm in 38 patients, and oculomotor palsy associated with a ruptured internal carotid artery aneurysm in 14 patients. Patients with SAH and 2 or more aneurysms of equal size but without any other evidence of aneurysm rupture were treated conservatively at that time and were excluded from this study. The remaining 11 patients had either incidental (n = 5; chronic headache, nausea, dizziness, visual disorders) or symptomatic (n = 6; cranial nerve deficits or cerebral infarction) UIAs (confirmed by a lumbar puncture).
Follow-up Methods
The detailed follow-up protocols have been reported previously. [8] [9] [10] [18] [19] [20] [21] [22] The follow-up evaluations were based on postal questionnaires and telephone interviews obtained from patients or proxies every 10 yr from the 1960s onwards. During the previous follow-up evaluations, 8, 10, 18, 19 the patients had been interviewed using a structured questionnaire focused on patient characteristics, previous diseases, hospital visits, medication, and health behavior. Patients who were alive between 1996 and 1998 were also interviewed at the outpatient clinic and a follow-up CTA was performed. The last questionnaires, based on telephone interviews, were filled in between 2011 and 2012.
Additional information on all the patients was obtained from medical records supplied by other hospitals and general practitioners, and the accuracy of the data collected with regard to diseases, medication, health behavior, and blood pressure (BP) levels was verified. Autopsy reports and official death certificates from the Causes of Death Register (Statistics Finland, Helsinki, Finland) were examined for all deceased patients. The follow-up was complete.
Risk Factors
BP values before the baseline data collection were acquired from other hospitals and general practitioners, and further measurements were obtained during the follow-up visits. "Acute phase" BP values obtained within 3 mo of SAH were excluded. In patients with multiple BP measurements, the values in the first and last quarter of the follow-up period were averaged. Hypertension was defined as a systolic pressure repeatedly >140 mm Hg or a diastolic pressure >90 mm Hg.
Alcohol consumption was recorded in approximate grams of absolute ethanol consumed within 1 wk (1 standard drink = 12 g of alcohol) throughout the follow-up period. Cigarette smoking was categorized as follows: never a smoker, formerly a regular smoker (quit before or during the follow-up), or a current smoker at the last follow-up. A family history of SAH was defined as ≥2 first-degree relatives with verified ruptured aneurysms.
Aneurysm Indices
Aneurysm volume, 10 aspect ratio, [11] [12] [13] [14] [15] [16] the bottleneck factor, 13, 16 height-width ratio, 13 and VOR 15 were calculated using standard projections of 2-dimensional conventional angiograms. The maximum (D), transverse (d), and height (h) diameters together with the neck width (n) were measured from each angiographic image of a UIA and used to calculate the aneurysm indices as follows: (1) 
2).
Statistical Analysis
Data were analyzed with IBM SPSS Statistics, version 23.0, for Windows (IBM Corp., Armonk, NY, USA). Categorical variables were compared using Fisher's exact 2-tailed test, while continuous variables were compared between groups by means of the Mann-Whitney U-test or Student's t-test. Changes in aneurysm indices before and after rupture were compared using the Wilcoxon Signed Rank test. Univariable associations between parameters were tested using the Spearman rank correlation coefficients (r s ).
For the life-table analysis and Cox proportional hazards regression model, each patient was followed up until SAH, death from a cause other than SAH, treatment of UIA (3 cases after follow-up lasting from 24.4 to 25.9 yr), or the final follow-up in 2011 or 2012. A Cox proportional hazards regression with a forward stepwise procedure (entry into the model if P < .1) and Wald statistics were employed to estimate hazard ratios (HRs) and 95% confidence intervals (CI). The test of significance was based on changes in the log (partial) likelihood. The variables known at the beginning of the follow-up included age, sex, morphological indices, and location of the largest UIA (that also was the ruptured one in all cases with multiple UIAs except for 1 patient where the second largest one later ruptured and was included in the analysis), presence of multiple UIAs, smoking status, alcohol consumption, a family history of ruptured intracranial aneurysms, a history of hypertension, and BP values. Interactions between significant predictors of a future rupture were analyzed in order to evaluate their possible deviation from the simple additive risk factor effects. In circumstances where morphological indices correlated closely with each other, the statistical models were adjusted for each parameter and for known SAH risk factors such as smoking, sex, age, and systolic BP. The proportionality assumption was confirmed. A P-value less than .05 was considered statistically significant.
RESULTS
Patient Characteristics and Follow-up Time
The baseline characteristics and aneurysm rupture status of the patients are shown in Table 1 . Age (inversely), cigarette smoking, and alcohol consumption associated with a future UIA rupture. All the morphological parameters were higher (P < .01) after the rupture than before (measured for 2 groups: 131 aneurysms with a prior SAH, and 21 index UIAs after rupture). A correlation matrix for the continuous variables is shown in Table 2 . Most of the UIA indices correlated with each other (eg, maximum diameter and volume, r s = 0.958, P < .01).
The median follow-up time per patient was 21.0 yr (mean 21.6, range 0.8-52.3 yr), and 34 (24%) of the 142 patients suffered from an SAH during the follow-up of 3064 person-years (annual incidence of SAH, 1.1%; Figure) . The cumulative rate of SAH at 30 yr of follow-up was 30.1% (95% CI, 21.3-38.9). The median time between diagnosis and a subsequent aneurysm rupture was 10.6 yr (mean 11.9, range 1.2-24.2 yr), and the median duration of follow-up in patients without an aneurysm rupture was 24.4 yr (mean 24.6, range 0.8-52.3 yr).
If UIAs were used as observation units instead of patients (aneurysm-based calculation), incidence rates were understandably lower since none of the additional UIAs ruptured in the same patient (see Table 1 , Supplemental Digital Content).
Risk Factors for Future Aneurysm Rupture
Univariable HRs for the risk factors for aneurysm rupture are shown in Table 3 . Current smoking, alcohol consumption, volume, aspect ratio maximum, the bottleneck factor, and VOR were all significant risk factors for the future aneurysm rupture, whereas the maximum diameter as a continuous variable did not achieve significance (P = .081; Table 3 ).
In multivariable analysis, the independent predictors for aneurysm rupture were current smoking (adjusted HR 3.15, 95% CI 1.31-7.56, P = .010), location in the anterior communicating artery (ACOA; 3.50, 1.20-10.23, P = .022), and aneurysm volume (1.06, 1.03-1.09 per 100 mm 3 , P < .001). Since the UIA indices were closely intercorrelated, each index was also tested separately. Apart from UIA volume, only the bottleneck factor and VOR as continuous variables were risk factors for SAH. The adjusted Cox regression models, including smoking, ACOA location, sex, age, systolic BP and all the aneurysm indices at baseline, are shown in Table 4 .
Since most of the ruptured aneurysms (n = 34) were small at baseline (maximum diameter, median 4 mm; range 2-26 mm; less than 7 mm in 24 cases; median volume 18 mm 3 ), the UIA indices were poor predictors for a future rupture when treated as categorical variables (analyzed in quartiles). In fact, only a UIA volume of 63 mm 3 or more (the highest quartile) was an independent risk factor for SAH with a comparable significance of maximum diameter of ≥7 mm obtained in large cohort studies (Table 5) . [6] [7] [8] [9] We did also an aneurysm-based analysis and the risk factors were essentially the same (see Table 2 , Supplemental Digital Content).
Risk Factors for UIA Growth
Eighty-seven patients had an angiographic imaging examination, either at the time of rupture during the follow-up (n = 27; all of whom had maximum diameter measurements, although only 21 had indices available because of missing data in 6 cases) or else at a follow-up visit (n = 60), and these images were used to assess any growth in the UIA (Figure) . The mean follow-up time for these 87 patients was 19.2 yr, and the maximum diameter of the UIA had increased by ≥1 mm in 40 cases (46.0%) and by ≥3 mm in 31 cases (36%), implying a mean growth of 2.48 ± 3.74 (SD) mm (median 0, range 0-17 mm, interquartile range 0-4 mm). The estimated annual growth rate was 0.31 ± 0.86 mm. The maximum diameter of the ruptured aneurysms (n = 27) had grown by ≥1 mm in all 27 patients and by ≥3 mm in 23 (74%) patients (mean growth 6.11 ± 4.20 mm, median 5 mm, range 1-17 mm, annual rate 0.92 ± 1.36 mm/yr), which was more (P < .001) than in the aneurysms that did not rupture, (n = 60), which had grown by ≥1 mm in 13 cases (22%) and by ≥3 mm in 8 (13%) cases (mean 0.85 ± 1.96 mm, median 0, range 0-9 mm, annual rate 0.04 ± 0.09 mm/yr). Since angiographic follow-up terminated at aneurysm rupture, the follow-up for the 27 patients in that group was shorter (P < .001) than for the 60 patients without a rupture (mean 12.0 ± 6.9 vs 22.4 ± 9.3 yr). Only 2 of the 27 patients with an aneurysm rupture (2 nonsmoking women) had had a control angiography before the rupture. The first of these had bilateral middle cerebral artery aneurysms of 4 mm in diameter, which grew by 1 and 5 mm, respectively, during the follow-up of 8.0 yr, leading to a fatal SAH 4.7 yr later, in 1974. The second patient had an ACOA aneurysm of 4 mm which did not grow at all during a follow-up time of 21.3 yr but grew thereafter by 2 mm and ruptured after a total follow-up of 23.7 yr, in 2000.
Current smokers at the end of the follow-up (n = 34) had (P < .05) higher UIA growth rates during the follow-up than those who had never smoked or the ex-smokers (n = 47; 3.44 ± 4.73 vs 1.57 ± 2.72 mm, 0.52 ± 1.27 vs 0.14 ± 0.35 mm/yr). An increase 3.1 ± 1.1 † 1.9 ± 1.0 1.6 ± 0.6 2.5 ± 0.9 † 1.7 ± 0.8 Aspect ratio (mean ± SD) 3.1 ± 1.1 † 1.8 ± 1.0 1.6 ± 0.6 2.5 ± 0.9 † 1.7 ± 0.7 Bottleneck factor (mean ± SD) 1.9 ± 0.7 † 1.5 ± 0.8 1.3 ± 0.5 1.8 ± 0.8 † 1.3 ± 0.6 Height-width ratio (mean ± SD) 1.7 ± 0. (21) 7 (21) 26 (24) 4 (19) 33 (23) Aneurysm size = largest diameter in mm. UIA: unruptured intracranial aneurysm. ACA: anterior cerebral artery, A2 = pericallosal artery. IQR: interquartile range (range between 25th and 75th percentiles). * P < .05 for difference in unruptured aneurysms between subsequent aneurysm rupture groups. † P < .01 for difference of aneurysm indices between ruptured (measured after the rupture) and unruptured aneurysms. 
DISCUSSION
Our prospective data suggest that baseline measurements of aneurysm volume, the bottleneck factor and VOR as continuous variables, and the maximum aneurysm diameter (≥7 mm) as a categorical variable seem to be independent risk factors for a future UIA rupture in a virtually lifelong follow-up. Other independent risk factors for rupture seem to be smoking, age (inversely), and an ACOA location. Aneurysm growth is likely to be associated with a future rupture. Smoking in particular, but not the aneurysm indices at baseline would seem to increase the likelihood of future growth of the aneurysm. Consequently, future morphological studies of UIAs should try to take into account smoking status or preferably cumulative dose of smoking. 23, 24 Smoking, which is the most important modifiable risk factor for SAH, 19, 25, 26 is likely to affect UIA formation and growth via hitherto unknown molecular mechanisms. The optimal angiographic follow-up interval for monitoring the growth rate of UIAs is obscure, as the growth rate and subsequent time of rupture remain unclear. In one of the cohort patients, a small UIA remained stable for over 20 yr but then ruptured.
A maximum UIA diameter of ≥7 mm was an independent risk factor for rupture, as has also been suggested in previous prospective studies. [6] [7] [8] [9] 18, 20 In any case, UIA diameter correlated closely with UIA volume, and a volume of ≥63 mm 3 (the largest quartile, the median maximum diameter of these UIAs was 8 mm, range 6-25 mm) was also associated with an increased risk of rupture. None of the other indices showed any comparable cutoff values for an increased risk of future rupture, most likely because 70% of the ruptured UIAs were less than 7 mm in diameter at baseline suggesting also that treatment decisions of small UIAs cannot be based on the widely used cutoff value of 7 mm. It is important to recognize that morphological parameters are designed especially for predicting the future rupture of small UIAs, which comprise the vast majority of all UIAs, as larger ones are less troublesome when determining the need for treatment. Unfortunately, without taking into account modifiable risk factors such as cumulative dose of smoking and BP, UIA volume or other morphological parameters do not seem to be optimal predictors for SAH, similar to what have been reported about the maximum baseline diameter of UIAs. The natural history of UIAs is not well known, especially since the various cohort studies have inevitably incorporated selection and treatment biases. Many have excluded, for example, patients with UIAs which entail a higher lifelong rupture risk, ie young patients, patients with large or growing UIAs, and smokers. 6, 7, 20 It is on account of such contradicting results and conclusions that a search has been undertaken for additional risk factors for UIA rupture. Along with the current increased interest in the flow dynamics of UIAs, various morphological parameters have recently been studied as predictors of future SAH, [11] [12] [13] [14] [15] but these investigations share 1 fundamental and crucial shortcoming: they have measured the predictor indices from already ruptured aneurysms and compared them with those of UIAs. As shown here, the morphological parameters of ruptured aneurysms are significantly higher than those of the same aneurysms prior to rupture. Thus, they represent the morphological features of ruptured aneurysms shortly before, during, or even after rupture, and it is clear that retrospective results cannot have predictive value with respect to estimating the long-term risk of rupture. This shortcoming may explain some of the conflicting results emerging from retrospective studies. [11] [12] [13] [14] [15] As in most previous follow-up studies, our study showed that observations and risks should be analyzed per patient, not per aneurysm, since the latter approach may lead to misleading incidence rates. Our and the Unruptured Cerebral Aneurysm Study of Japan (UCAS Japan) data 7, 20 showed also that in multiple UIA cases, additional UIAs did not rupture during remaining follow-up if one UIA had already ruptured (see Tables 1 and 2 , Supplemental Digital Content).
Limitations
The strengths of this prospective study include the completeness and long duration of the follow-up and the limited treatment selection bias. 8 On the other hand, the overall cohort size was modest by comparison with the large multicenter cohorts with short follow-up times. 6, 7 This was due to the historical policy governing aneurysm treatment, according to which only ruptured aneurysms of good-grade patients of working age were treated, leaving us the possibility of following up unruptured UIAs. Despite the small cohort size, however, the number of SAHs was relatively high because of the long duration of the follow-up by comparison with the much larger landmark studies. 6, 7 Furthermore, as a considerable number of patients had been excluded from previous natural history studies (treatment bias based on UIA size, UIA growth, young age, cigarette smoking, etc.) either before (58%) 6, 20 or during (32%, 48%) 6,7,20 the follow-up, our results may reflect the natural history more reliably. 20 Even so, the findings presented here cannot necessarily be generalized, at least not to patients of advanced age. Finnish people have also been considered to be subject to a higher risk of aneurysm rupture. 20 In Finland, the incidence of SAH is not higher than elsewhere when the study design with inclusion and exclusion criteria, accuracy of diagnosis, and distribution of sex and age of population (standardization) are taken into account. 27, 28 In fact, the Nordic countries seem to have similar SAH incidences. 28 Finally, all our initial UIA measurements were obtained from 2-dimensional conventional angiograms, which may yield less accurate measures than 3-dimensional angiograms. Moreover, we could measure only the most commonly used indices and not 3-dimensional parameters. However, even though this shortcoming creates an Abbreviations: CI: confidence interval; HR = hazard ratio. In the various multivariable models, the HRs for each parameter index were adjusted for current smoking and for the nonsignificant variables sex, age, and systolic blood pressure at baseline. * P < .05 † P < .01 ‡ P = .098 inherent but as yet unknown measurement bias, the distributions of the morphological indices were similar to those obtained in previous studies, supporting the view that our results are in all probability reasonable.
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CONCLUSION
The various morphological parameters of UIAs do not seem to offer significant additional benefit when estimating the longterm risk of UIA rupture, especially in comparison with the simple and widely used maximum size of the UIA. Importantly, morphological measurements performed after rupture cannot be used in prediction models. However, given the relatively small cohort size, studied parameters might evolve as modest predictors in larger prospective cohorts. Whether any modest value improves the reliability of predictive models, or adds to clinical decisionmaking processes, remain unclear. Modifiable risk factors still play an essential role in the estimation of the lifelong risk of UIA rupture, but morphological features may perhaps serve as supportive tools in decision-making processes.
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